Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
about
Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Comparative effectiveness and safety of cefdinir and amoxicillin-clavulanate in treatment of acute community-acquired bacterial sinusitis. Cefdinir Sinusitis Study Group.Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: antimicrobial susceptibility patterns from the SENTRY antimicrobial Surveillance Program (United States and Canada, 1997)Using hospital antibiogram data to assess regional pneumococcal resistance to antibioticsAntimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.Therapeutic efficacy of meropenem for treatment of experimental penicillin-resistant pneumococcal meningitisEvaluation of the Dade MicroScan MICroSTREP antimicrobial susceptibility testing panel with selected Streptococcus pneumoniae challenge strains and recent clinical isolates.Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.Antipneumococcal activities of levofloxacin and clarithromycin as determined by agar dilution, microdilution, E-test, and disk diffusion methodologies.Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media.Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agentsAntipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococciAntipneumococcal activity of grepafloxacin compared to that of other agents by time-kill methodology.Antibiotic susceptibility patterns of Streptococcus pneumoniae in china and comparison of MICs by agar dilution and E-test methods.In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniaeFactors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010.Determination of trimethoprim-sulfamethoxazole resistance in Streptococcus pneumoniae by using the E test with Mueller-Hinton agar supplemented with sheep or horse blood may be unreliable. The Pneumococcal Study Group.Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologiesAbility of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae.Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococciActivities of newer fluoroquinolones against Streptococcus pneumoniae clinical isolates including those with mutations in the gyrA, parC, and parE lociPharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.Comparative in vitro activities of amoxicillin-clavulanate against aerobic and anaerobic bacteria isolated from antral puncture specimens from patients with sinusitisEmergence in france of multiple clones of clinical Streptococcus pneumoniae isolates with high-level resistance to amoxicillinSusceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance studyPrevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. studyPostantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria.Antipneumococcal activities of gemifloxacin compared to those of nine other agentsPrevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seIn vivo activity and pharmacokinetics of ziracin (SCH27899), a new long-acting everninomicin antibiotic, in a murine model of penicillin-susceptible or penicillin-resistant pneumococcal pneumonia.Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998)Antipneumococcal activity of ABT-773 compared to those of 10 other agents.Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from pediatric patients in Singapore.Benchmarking the in vitro activities of moxifloxacin and comparator agents against recent respiratory isolates from 377 medical centers throughout the United States.
P2860
Q24519005-11A6C354-6016-45F5-B23B-5267F525B266Q30251593-C5AFFF09-1C58-48B9-A8C4-104A14F16F0DQ30452909-6DD4ECA7-591A-4999-8ED0-9EEC9C2FCDD6Q30453668-3FC6FBC4-E454-4F0B-8EED-F3F8ACE5057BQ30772203-1E915021-858F-42FE-B365-EA1950369F8BQ33181094-1879DF79-8B9E-4E4C-81F1-52705CD4D94BQ33654490-BE3AE9E1-794F-4388-86FC-A4DBFCC12ABDQ33659832-9A2EB33A-56FC-45EA-9696-AEFCEDB9702CQ33672446-8DBA7B7E-368D-45F9-9D89-5288654AFEA9Q33685617-6AC09682-5436-4B58-8F25-D3FAE0165AE7Q33691073-E5CB3BB1-977A-405C-A1E5-1D41E7344E39Q33691239-13CAB342-40A0-4799-B548-C75F6750EDEFQ33692938-546DA14A-9672-42BC-95A0-4925FFD69E64Q33693715-03671644-CB43-479B-A96B-0DA86843D00AQ33694946-0E4297E7-B02F-404F-AB30-D5D7E7510D27Q33696032-8A209113-97B9-433D-9B54-300364A4441FQ33696166-D97A37EC-E5E5-4C5F-B210-6570DC489016Q33699406-F04775C4-93AB-49AC-828A-9E6439AEE4EDQ33701390-E846A134-3AB3-48A9-B938-C3B9F1FF5D40Q33798133-2AC14262-05BC-4911-9826-68DD86C74248Q33958232-7A4D693C-886A-4C5C-99CF-0EFDAFC68DF4Q33966371-09D48F19-8163-48E2-827F-E3AB2E76A0BBQ33970955-7818246C-C67A-4D8F-BB7E-A36C1F051696Q33971039-4353BFFD-7C9D-4DF4-A2AE-B87BA2A79F80Q33974710-348F4E9C-0929-4951-94CF-2320C0097874Q33976055-74195161-C41A-4668-AA3C-6F5595914E0DQ33976517-C5245141-33A6-4601-A49D-8C88B0FF87D6Q33976538-64C2973E-745D-465F-9290-99D75037C869Q33976988-15B11BC3-EB54-4914-96CC-BAA7F9031D5EQ33977347-133C95AE-CD12-437A-88EF-A693BF196EC0Q33977884-11B1D6AF-73A8-48D4-9DCA-CA2ADB6ED60CQ33977989-313F047C-8305-4D0F-8ADE-41DBE1904DAAQ33978553-F899D104-08B4-431A-BB1D-A24CA3259A16Q33978679-97E9E6FF-D707-477A-B3D1-B2C75568E4C2Q33978849-8858B3E4-CFF7-4E93-AB76-26840B4BF6C3Q33979192-E38D14A3-CC00-41F1-BC23-F6350A0590AEQ33979791-80F765DB-5F9A-45FE-995C-2FB51A20B8B9Q33980037-3C2F6005-2B8A-468E-8C7B-1B6D44C823CDQ33980305-64187AE9-93A0-40B8-BADB-B1F929160C24Q33980689-7676CDDE-B708-4258-8D0F-DA1A487A27DF
P2860
Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Antimicrobial resistance of St ...... r national surveillance study.
@ast
Antimicrobial resistance of St ...... r national surveillance study.
@en
type
label
Antimicrobial resistance of St ...... r national surveillance study.
@ast
Antimicrobial resistance of St ...... r national surveillance study.
@en
prefLabel
Antimicrobial resistance of St ...... r national surveillance study.
@ast
Antimicrobial resistance of St ...... r national surveillance study.
@en
P2093
P2860
P1476
Antimicrobial resistance of St ...... r national surveillance study.
@en
P2093
Brueggemann A
Holley HP Jr
P2860
P304
P407
P577
1996-05-01T00:00:00Z